Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 August 2021 | Story Leonie Bolleurs | Photo Supplied
Tinus Viljoen (second from the left) is responsible for waste management at the university. Here he is pictured at the new chemical waste facility on the western side of the Bloemfontein Campus. With him, on his left, is Nico Janse van Rensburg, Senior Director, University Estates; Prof Danie Vermeulen, Dean of the Faculty of Natural and Agricultural Sciences; and on the far right is Benedict Mochesela, officer at University Estates.

A new chemical waste facility on the western side of the Bloemfontein Campus started functioning in July 2021 and will enhance the safe storage of hazardous materials on campus.

Since the safety of its staff and students are a key priority for the university, as stipulated in its strategic plan, a facility such as this plays an essential role in reducing any health risks and even the possibility of an explosion.

Tinus Viljoen, a Lecturer in the Department of Genetics, concurs that this facility makes the university a safer place because there are less toxic and flammable waste lying around in the labs. 

Besides his role as lecturer, he is responsible for waste management, including the collection of hazardous waste internally, classifying it, and arranging for it to be collected by accredited waste companies. 

A safer space

Waste previously stored in the Genetics Building is now kept at the new facility. Viljoen is of the opinion that this new space is safer because fewer students and staff have access to the western campus. “The chemical waste tends to smell, and on this part of the campus it is out of the way,” he says.

He also says that it helps to have a central place to store the waste, because of logistical reasons. “It makes the overall waste management easier.”

It is mainly inorganic and organic liquid/solid waste, contaminated glass, contaminated solids (e.g., filter paper and gloves), acid waste, and expired chemicals that are stored at the facility. 

This facility makes the university a safer place because there are less toxic and flammable waste lying around in the labs. – Tinus Viljoen

Adhering to legislation

He explains that he is notified by departments in the Faculty of Natural and Agricultural Sciences when they have waste to collect and that he then collects it on Fridays.

Viljoen continues: “The chemical waste is then classified according to the various waste streams and stored in large 210 l drums. When the drums are full, I contact an accredited hazardous waste company to remove, transport, and dispose of the various waste according to strict legislation, constituting the National Environmental Management Act (Act 107 of 1998), the National Environmental Management: Waste Act, 2008 (Act 59 of 2008), the Hazardous Substances Act (Act 5 of 1973), and the National Road Traffic Act, 93 of 1996 (NRTA).”

“The majority of the waste is transported to a hazardous landfill in Gauteng and the rest are incinerated,” he concludes. 

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept